TrialJournal of translational medicine2011

Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial.

Soyoung Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.